Get the Stockscreener App
24.02
0.25%
0.06
Pre-market:
24.05
0.03
+0.12%
Privia Health Group Inc stock is traded at $24.02, with a volume of 850.98K.
It is up +0.25% in the last 24 hours and down -0.50% over the past month.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
See More
Previous Close:
$23.96
Open:
$24.03
24h Volume:
850.98K
Relative Volume:
1.31
Market Cap:
$2.89B
Revenue:
$1.72B
Net Income/Loss:
$12.82M
P/E Ratio:
240.20
EPS:
0.1
Net Cash Flow:
$98.59M
1W Performance:
-6.50%
1M Performance:
-0.50%
6M Performance:
+27.49%
1Y Performance:
+11.00%
1-Day Range:
$23.70
$24.32
1-Week Range:
$23.41
$25.88
52-Week Range:
$15.92
$26.04
Privia Health Group Inc Stock (PRVA) Company Profile
Name
Privia Health Group Inc
Sector
Industry
Phone
571-366-8850
Address
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
24.02 | 2.89B | 1.72B | 12.82M | 98.59M | 0.10 |
|
VEEV
Veeva Systems Inc
|
233.46 | 37.90B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
74.01 | 12.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
64.30 | 12.07B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
95.78 | 8.30B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.50 | 7.84B | 640.44M | -743.28M | -206.93M | -11.29 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-16-24 | Initiated | Macquarie | Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Feb-22-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-03-23 | Initiated | Goldman | Buy |
| Dec-09-22 | Initiated | Stifel | Buy |
| Dec-08-22 | Initiated | UBS | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| May-03-22 | Initiated | BofA Securities | Buy |
| Apr-28-22 | Initiated | BTIG Research | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Feb-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-03-22 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| May-24-21 | Initiated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Credit Suisse | Outperform |
| May-24-21 | Initiated | JP Morgan | Overweight |
| May-24-21 | Initiated | Piper Sandler | Overweight |
| May-24-21 | Initiated | Truist | Buy |
| May-24-21 | Initiated | William Blair | Outperform |
View All
Privia Health Group Inc Stock (PRVA) Latest News
Top Executives at Privia Health Group Cash Out on Stock Sales - TipRanks
Privia Health CFO David Mountcastle sells $141,658 in stock - Investing.com India
Privia Health EVP Fargis Edward C sells shares worth $120,255 - Investing.com
Privia Health CFO David Mountcastle sells $141,658 in stock By Investing.com - Investing.com UK
Privia Health Group Executives Sell Shares for Tax Obligations - TradingView
Proficio Capital Partners LLC Invests $464,000 in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
PRVA Shares Experience Decline in Value - Knox Daily
Privia Health adjusts executive pay structure By Investing.com - Investing.com South Africa
Privia Health adjusts executive pay structure - Investing.com India
Bank of New York Mellon Corp Sells 227,357 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Jefferies raises Privia Health stock price target to $29 - Investing.com India
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 - MSN
When Should You Buy Privia Health Group, Inc. (NASDAQ:PRVA)? - Yahoo Finance UK
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $30.00 - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $40.00 - Defense World
Leerink Partnrs Has Pessimistic View of PRVA Q1 Earnings - Defense World
Canaccord lifts Privia Health stock target to $30, maintains Buy - Investing.com
Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $25.19 - MarketBeat
Versor Investments LP Acquires New Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2024 Earnings Call Transcript - MSN
JMP raises Privia Health stock target to $29 on strong outlook - Investing.com Canada
Privia Health Group Reports Strong 2024 Financial Results - TipRanks
Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Taking on analysts’ expectations and winning: Privia Health Group Inc (PRVA) - SETE News
Truist Adjusts Price Target on Privia Health Group to $30 From $27, Maintains Buy Rating - Marketscreener.com
UBS Adjusts Price Target on Privia Health Group to $31 From $27, Keeps Buy Rating - Marketscreener.com
JMP raises Privia Health stock target to $29 on strong outlook By Investing.com - Investing.com South Africa
Privia Health: Q4 Earnings Snapshot - The Herald Review
Rhumbline Advisers Grows Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group’s Strong Performance and Promising Outlook Justifies Buy Rating - TipRanks
Privia Health’s 2024 Earnings Call Highlights Growth - TipRanks
Citi raises Privia Health target to $32, maintains Buy rating By Investing.com - Investing.com Australia
Piper Sandler raises Privia Health stock target to $40 By Investing.com - Investing.com Canada
Piper Sandler raises Privia Health stock target to $40 - Investing.com India
Privia Health stock target raised to $30 by TD Cowen - Investing.com Canada
Earnings call transcript: Privia Health Q4 2024 beats earnings forecast By Investing.com - Investing.com Canada
Citi raises Privia Health target to $32, maintains Buy rating - Investing.com India
Privia Health stock hits 52-week high at $24.16 amid growth - MSN
Privia Health Group rises on quarterly revenue growth - TradingView
Privia Health shares surge 7% on strong Q4 earnings beat - Investing.com India
Privia Health stock hits 52-week high at $25.73 amid growth - Investing.com Australia
Privia Health shares surge 7% on strong Q4 earnings beat By Investing.com - Investing.com Canada
Privia Health stock hits 52-week high at $25.73 amid growth By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q4 2024 beats earnings forecast - Investing.com
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings - Yahoo Finance
Privia Health Group Inc Stock (PRVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.78%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):